Mangoceuticals Inc (MGRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,707 | -9,212 | -1,998 | 0 | N/A |
| Depreciation Amortization | 732 | 25 | 4 | 0 | N/A |
| Other Working Capital | 660 | -14 | 222 | 0 | N/A |
| Other Operating Activity | 2,452 | 2,204 | 426 | 0 | 0 |
| Operating Cash Flow | $-4,864 | $-6,997 | $-1,347 | $0 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 65 | -4 | -43 | 0 | N/A |
| Investing Cash Flow | $65 | $-4 | $-43 | $0 | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 150 | N/A | 75 | N/A | N/A |
| Common Stock Issued | 1,328 | 7,225 | 2,000 | N/A | N/A |
| Other Financing Activity | 2,650 | -168 | -25 | 0 | 0 |
| Financing Cash Flow | $4,128 | $7,057 | $2,050 | $0 | $N/A |
| Exchange Rate Effect | -10 | N/A | N/A | 0 | N/A |
| Beginning Cash Position | 739 | 683 | 23 | 0 | N/A |
| End Cash Position | 59 | 739 | 683 | 0 | N/A |
| Net Cash Flow | $-680 | $56 | $660 | $0 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,864 | -6,997 | -1,347 | 0 | N/A |
| Capital Expenditure | N/A | -4 | -43 | N/A | N/A |
| Free Cash Flow | -4,864 | -7,001 | -1,390 | 0 | 0 |